On March 16, 2015, the House of Representatives is scheduled to consider the following health policy legislation:
- H.R. 284, the Medicare DMEPOS Competitive Bidding Improvement Act of 2015 -- which would require Medicare suppliers that bid under a DME, prosthetics, orthotics, and supplies (DMEPOS) competitive bidding program to submit binding bids or risk forfeiture of a surety bond;
- H.R. 876, the "NOTICE Act" – which would require hospitals to provide certain notifications to individuals classified as being under observation status rather than admitted as inpatients;
- H.R. 639, Improving Regulatory Transparency for New Medical Therapies Act -- to amend the Controlled Substances Act to improve the efficiency, transparency, and consistency of the Drug Enforcement Agency's process for scheduling new drugs;
- H.R. 647, Access to Life-Saving Trauma Care for All Americans Act -- to reauthorize language from the Public Health Service Act to fund trauma care centers; and
- H.R. 648, Trauma Systems and Regionalization of Emergency Care Reauthorization Act -- to reauthorize grants supporting state and rural development of trauma systems and authorize new regionalized emergency care model pilot projects.
This article is presented for informational purposes only and is not intended to constitute legal advice.